238 related articles for article (PubMed ID: 28433777)
1. Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses.
Hu Y; Wang Y; Li F; Ma C; Wang J
Eur J Med Chem; 2017 Jul; 135():70-76. PubMed ID: 28433777
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
Li F; Ma C; Hu Y; Wang Y; Wang J
ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
[TBL] [Abstract][Full Text] [Related]
3. Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction.
Li F; Hu Y; Wang Y; Ma C; Wang J
J Med Chem; 2017 Feb; 60(4):1580-1590. PubMed ID: 28182419
[TBL] [Abstract][Full Text] [Related]
4. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
[TBL] [Abstract][Full Text] [Related]
5. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
6. Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers.
Musharrafieh R; Ma C; Wang J
Antiviral Res; 2018 May; 153():10-22. PubMed ID: 29518414
[TBL] [Abstract][Full Text] [Related]
7. Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with
Cáceres CJ; Hu Y; Cárdenas-García S; Wu X; Tan H; Carnaccini S; Gay LC; Geiger G; Ma C; Zhang QY; Rajao D; Perez DR; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):1832-1848. PubMed ID: 34427541
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.
Wang Y; Hu Y; Xu S; Zhang Y; Musharrafieh R; Hau RK; Ma C; Wang J
J Med Chem; 2018 Feb; 61(3):1074-1085. PubMed ID: 29341607
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
Ma C; Zhang J; Wang J
Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
Li F; Ma C; DeGrado WF; Wang J
J Med Chem; 2016 Feb; 59(3):1207-16. PubMed ID: 26771709
[TBL] [Abstract][Full Text] [Related]
11. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
[TBL] [Abstract][Full Text] [Related]
12. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
[TBL] [Abstract][Full Text] [Related]
13. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
Musharrafieh R; Ma C; Wang J
Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
[TBL] [Abstract][Full Text] [Related]
14. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
[TBL] [Abstract][Full Text] [Related]
15. Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel.
Wang J; Ma C; Wu Y; Lamb RA; Pinto LH; DeGrado WF
J Am Chem Soc; 2011 Sep; 133(35):13844-7. PubMed ID: 21819109
[TBL] [Abstract][Full Text] [Related]
16. Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
Ma C; Li F; Musharrafieh RG; Wang J
Antiviral Res; 2016 Sep; 133():62-72. PubMed ID: 27478032
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of pinane oxime derivatives as novel anti-influenza agents.
Dong J; Xiao M; Ma Q; Zhang G; Zhao W; Kong M; Zhang Y; Qiu L; Hu W
Bioorg Chem; 2020 Sep; 102():104106. PubMed ID: 32739481
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
Wang J; Ma C; Wang J; Jo H; Canturk B; Fiorin G; Pinto LH; Lamb RA; Klein ML; DeGrado WF
J Med Chem; 2013 Apr; 56(7):2804-12. PubMed ID: 23437766
[TBL] [Abstract][Full Text] [Related]
19. Structure-Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers.
Hu Y; Hau RK; Wang Y; Tuohy P; Zhang Y; Xu S; Ma C; Wang J
ACS Med Chem Lett; 2018 Nov; 9(11):1111-1116. PubMed ID: 30429954
[TBL] [Abstract][Full Text] [Related]
20. Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.
Wu Y; Canturk B; Jo H; Ma C; Gianti E; Klein ML; Pinto LH; Lamb RA; Fiorin G; Wang J; DeGrado WF
J Am Chem Soc; 2014 Dec; 136(52):17987-95. PubMed ID: 25470189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
